This statistic shows the total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017, sorted by oncology and non-oncology companies. In 2016, the value of all non-oncology rare disease therapeutic companies combined was some 252 billion U.S. dollars.
Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)*
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Torreya Partners. (October 27, 2017). Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)* [Graph]. In Statista. Retrieved December 31, 2024, from https://www.statista.com/statistics/784222/enterprise-value-of-top-rare-disease-therapeutic-companies-worldwide/
Torreya Partners. "Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)*." Chart. October 27, 2017. Statista. Accessed December 31, 2024. https://www.statista.com/statistics/784222/enterprise-value-of-top-rare-disease-therapeutic-companies-worldwide/
Torreya Partners. (2017). Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)*. Statista. Statista Inc.. Accessed: December 31, 2024. https://www.statista.com/statistics/784222/enterprise-value-of-top-rare-disease-therapeutic-companies-worldwide/
Torreya Partners. "Total Enterprise Value of Top Rare Disease Therapeutic Companies Worldwide from 2000 to 2017 (in Million U.S. Dollars)*." Statista, Statista Inc., 27 Oct 2017, https://www.statista.com/statistics/784222/enterprise-value-of-top-rare-disease-therapeutic-companies-worldwide/
Torreya Partners, Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)* Statista, https://www.statista.com/statistics/784222/enterprise-value-of-top-rare-disease-therapeutic-companies-worldwide/ (last visited December 31, 2024)
Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)* [Graph], Torreya Partners, October 27, 2017. [Online]. Available: https://www.statista.com/statistics/784222/enterprise-value-of-top-rare-disease-therapeutic-companies-worldwide/
